Literature DB >> 36203492

A Pre-clinical Standard Operating Procedure for Evaluating Orthobiologics in an In Vivo Rat Spinal Fusion Model.

Andrew L Alejo1,2, Scott McDermott3, Yusuf Khalil1,2, Hope C Ball2, Gabrielle T Robinson4,2, Ernesto Solorzano4,2, Amanda M Alejo1,2, Jacob Douglas1,2, Trinity K Samson1,4,2, Jesse W Young1,4,2, Fayez F Safadi1,4,2,5,6.   

Abstract

The rat animal model is a cost effective and reliable model used in spinal pre-clinical research. Complications from various surgical procedures in humans often arise that were based on these pre-clinical animal models. Therefore safe and efficacious pre-clinical animal models are needed to establish continuity into clinical trials. A Standard Operating Procedure (SOP) is a validated method that allows researchers to safely and carefully replicate previously successful surgical techniques. Thus, the aim of this study is to describe in detail the procedures involved in a common rat bilateral posterolateral intertransverse spinal fusion SOP used to test the efficacy and safety different orthobiologics using a collagen-soaked sponge as an orthobiologic carrier. Only two orthobiologics are currently FDA approved for spinal fusion surgery which include recombinant bone morphogenetic protein 2 (rhBMP-2), and I-FACTOR. While there are many additional orthobiologics currently being tested, one way to show their safety profile and gain FDA approval, is to use well established pre-clinical animal models. A preoperative, intraoperative, and postoperative surgical setup including specific anesthesia and euthanasia protocols are outlined. Furthermore, we describe different postoperative methods used to validate the spinal fusion SOP, which include μCT analysis, histopathology, biomechanical testing, and blood analysis. This SOP can help increase validity, transparency, efficacy, and reproducibly in future rat spinal fusion surgery procedures.

Entities:  

Keywords:  Orthobiologics; Posterolateral intertransverse fusion model; Protocols; Rat model; Spinal fusion; Standard Operating Procedure (SOP); rhBMP-2

Year:  2022        PMID: 36203492      PMCID: PMC9534599          DOI: 10.26502/josm.511500060

Source DB:  PubMed          Journal:  J Orthop Sports Med        ISSN: 2688-5115


  163 in total

1.  Wound complications associated with bone morphogenetic protein-2 in orthopaedic trauma surgery.

Authors:  Daniel S Chan; Joshua Garland; Anthony Infante; Roy W Sanders; H Claude Sagi
Journal:  J Orthop Trauma       Date:  2014-10       Impact factor: 2.512

2.  Publication trends in model organism research.

Authors:  Michael R Dietrich; Rachel A Ankeny; Patrick M Chen
Journal:  Genetics       Date:  2014-11       Impact factor: 4.562

Review 3.  [Lumbar fusion-Indications and techniques].

Authors:  K J Schnake; D Rappert; B Storzer; S Schreyer; F Hilber; C Mehren
Journal:  Orthopade       Date:  2019-01       Impact factor: 1.087

4.  Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion.

Authors:  Lisa B E Shields; George H Raque; Steven D Glassman; Mitchell Campbell; Todd Vitaz; John Harpring; Christopher B Shields
Journal:  Spine (Phila Pa 1976)       Date:  2006-03-01       Impact factor: 3.468

Review 5.  Trends in lumbar spinal fusion-a literature review.

Authors:  Marie-Jacqueline Reisener; Matthias Pumberger; Jennifer Shue; Federico P Girardi; Alexander P Hughes
Journal:  J Spine Surg       Date:  2020-12

Review 6.  Estrogen and bone health in men and women.

Authors:  Jane A Cauley
Journal:  Steroids       Date:  2014-12-30       Impact factor: 2.668

7.  Single level posterolateral lumbar fusion in a New Zealand White rabbit (Oryctolagus cuniculus) model: Surgical anatomy, operative technique, autograft fusion rates, and perioperative care.

Authors:  James D Crowley; Rema A Oliver; Michael J Dan; Daniel J Wills; John W Rawlinson; Rebekah A Crasto; James M O'Connor; Gregory J Mitchell; Christopher J Tan; William R Walsh
Journal:  JOR Spine       Date:  2020-12-23

Review 8.  Ovariectomized rat model of osteoporosis: a practical guide.

Authors:  Nasibeh Yousefzadeh; Khosrow Kashfi; Sajad Jeddi; Asghar Ghasemi
Journal:  EXCLI J       Date:  2020-01-10       Impact factor: 4.068

9.  Cost Analysis of Single-Level Lumbar Fusions.

Authors:  Daniel Beckerman; Melissa Esparza; Sun Ik Lee; Sigurd H Berven; S Samuel Bederman; Serena S Hu; Shane Burch; Vedat Deviren; Bobby Tay; Praveen V Mummaneni; Dean Chou; Christopher P Ames
Journal:  Global Spine J       Date:  2019-06-24

Review 10.  Ultra-Low Dose Cytokines in Rheumatoid Arthritis, Three Birds with One Stone as the Rationale of the 2LARTH® Micro-Immunotherapy Treatment.

Authors:  Camille Jacques; Ilaria Floris; Béatrice Lejeune
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.